Results 21 to 30 of about 10,858,974 (235)
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma. [PDF]
Many mammalian viruses have properties that can be commandeered for the treatment of cancer. These characteristics include preferential infection and replication in tumor cells, the initiation of tumor cell lysis, and the induction of innate and adaptive anti-tumor immunity. Furthermore, viruses can be genetically engineered to reduce pathogenicity and
Bommareddy PK +3 more
europepmc +3 more sources
Successful treatment of in-transit metastatic melanoma with combination intralesional T-VEC and topical imiquimod immunotherapy. [PDF]
In-transit metastases of malignant melanoma pose a significant clinical challenge, particularly in patients with contraindications to systemic therapies. While surgical excision and systemic immunotherapies remain standard treatments, localized therapies such as intralesional talimogene laherparepvec (T-VEC) and topical imiquimod, which stimulate tumor-
Lenga M +7 more
europepmc +4 more sources
Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma. [PDF]
SIMPLE SUMMARY: Since T-VEC is already approved for treatment of melanoma, its promising efficacy shown here also for NUT carcinoma (NC) cell lines may create a rapid transition to individual treatments as well as clinical trials in NC patients. The idea
Ohnesorge PV +11 more
europepmc +2 more sources
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. [PDF]
Background Talimogene laherparepvec (T-VEC) is a licensed therapy for use in melanoma patients of stage IIIB-IVM1a with injectable, unresectable metastatic lesions in Europe.
Ressler JM +15 more
europepmc +2 more sources
T-VEC: a tool for developing critical systems [PDF]
This paper describes the specification-based testing and analysis tools, and associated processes, that were used to develop and certify safety-critical avionics systems in an industrial organization. These tools comprise an integrated development environment supporting specification acquisition and analysis, requirement-based automatic test vector ...
M.R. Blackburn, R.D. Busser
openaire +1 more source
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792) +9 more
core +1 more source
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792) +9 more
core +1 more source
T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792) +9 more
core +1 more source
T-VEC for Cancer Therapy: Applications, Limitations, and Potentials
Cancer is a great threat to human health, and immunotherapy has become an important means to treat cancer in recent years. Talimogene laherparepvec (T-VEC), as an oncolytic virus, is one of the immunotherapy for melanoma. This article explains its mechanism, and then summarizes its clinical applications, including the effects and safety of monotherapy ...
openaire +1 more source
Optimal strong approximation for quadrics over $\mathbb{F}_q[t]$ [PDF]
Suppose $q$ is a fixed odd prime power, $F(\vec{x})$ is a non-degenerate quadratic form over $\mathbb{F}_q[t]$ of discriminant $\Delta$ in $d\geq 5$ variables $\vec{x}$, and $f,g\in\mathbb{F}_q[t]$, $\boldsymbol{\lambda}\in\mathbb{F}_q[t]^d$.
Zargar, Masoud, Sardari, Naser T.
core

